CeraVx B.V. is a privately held global biotechnology company developing and commercializing a proprietary drug delivery platform based on a ceramic micro-needle array patches (CeraMAPs™). The CeraMaps technology was initially developed at the University of Twente, MESA+, Institute for Nanotechnology, The Netherlands. The company is focussing on prophylactic and therapeutic vaccines. In 2024 CeraVx acquired the propietary micro-needle technology from MLT.
Company Details
- Employees
- 9
- Founded
- 2024
- Address
- Leiden Bioscience Park, Biopartner 4, Unit 4358, Robert Boyleweg 4,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- mylifetechnologies.nl
- Keywords
- dermal drug delivery, vaccine delivery, mRNA nano particles, Therapeutic vaccines, infectious diseases, prophylactic vaccines, Skin patches, Leiden Bio Science Park.
- HQ
- Leiden
Ceravx Questions
Ceravx's website is mylifetechnologies.nl
Ceravx's LinkedIn profile is https://nl.linkedin.com/company/ceravxx
Ceravx has
9 employees.
View email and phone details for 9
employees at Ceravx.
Ceravx's industry is
Pharmaceutical Manufacturing
Ceravx's categories are Pharmaceutical Manufacturing
Ceravx's founding year is 2024
